Salvia BioElectronics (Series B)
Funding Details
- Awarder
- RSS - tech.eu
- Date Award
- May 27, 2025
- Vertical
- Healthtech
- Funding URL
- View Funding Page
- Funding Amount:
- $60,000,000
Company Info
- Traction
- Currently conducting the RECLAIM clinical trial, a multi-center, double-blind, sham-controlled study in Europe and Australia, with U.S. trials planned next.
- Founders
- Hubert Martens
- Company Description
- Salvia BioElectronics develops neuromodulation devices for migraine treatment and management.
- Market
- Chronic migraine treatment
- Location
- Eindhoven, Netherlands
- Coinvestors
- Innovation Industries, Invest-NL, EIC Fund, Inkef, Panakès Partners, SHS Capital, Dolby Family Ventures, Brabant Development Agency (BOM), Thuja Capital